Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA Department of Urology.
[More]
When it comes to a cancer diagnosis, timing can be everything - the sooner it's found, the more treatable it is. But when and how often should someone get screened?
[More]
Uroplasty, Inc., a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today highlighted the 3-year results of the STEP Study on percutaneous tibial nerve stimulation treatments for overactive bladder using Uroplasty's Urgent PC Neuromodulation System.
[More]
While the percentage of kidney transplants involving live donors has remained stable for other minority populations, African Americans have seen a decline in live donors even as more of them receive kidney transplants, according to a study by Henry Ford Hospital in Detroit.
[More]
Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic products for use in personalized medicine research and clinical diagnostics, today announced the presentation of data at the American Urological Association Annual Meeting in San Diego demonstrating the performance of urine exosome technology in accurately predicting the outcome of a prostate biopsy.
[More]
A new genomic test for prostate cancer can help predict whether men are more likely to harbor an aggressive form of the disease, according to a new UC San Francisco study.
[More]
Robot-assisted surgery to remove kidney cancers has seen a rapid increase in use, and has both replaced and proven safer than laparoscopic procedures for the same purpose, according to a study by the Vattikuti Urology Institute at Henry Ford Hospital in Detroit.
[More]
Patients with advanced bladder cancers that are surgically removed might need additional therapy to prevent recurrence in certain situations, a new UT Southwestern Medical Center study suggests.
[More]
While the number of people - especially women - who have a minimally invasive procedure to remove kidney stones has risen in recent years, so has the rate of complications related to the surgery, according to a published study by Henry Ford Hospital in Detroit.
[More]
An international group of investigators, led by researchers at Thomas Jefferson University's Kimmel Cancer Center, have solved the mystery of why a substantial percentage of castrate-resistant metastatic prostate cancer cells contain abnormally high levels of the pro-growth protein Stat5.
[More]
Based on a major effort co-led by Richard Valicenti, UC Davis Department of Radiation Oncology Professor and Chair, the nation's leading urological and radiation oncology organizations today announced a new guideline for radiation therapy after prostatectomy.
[More]
A new, cost-effective endoscopic option is now available to urologists. Physicians can use the Flexor® Vue™ Deflecting Endoscopic System during urological procedures to access and visualize body cavities or organs.
[More]
Giving patients better access to primary health care could save nearly $4 billion a year in unnecessary emergency room visits for a single common complaint - urinary tract infections - according to a study by the Vattikuti Urology Institute at Henry Ford Hospital in Detroit.
[More]
The American Society for Radiation Oncology (ASTRO) and the American Urological Association (AUA) are pleased to announce the publication of the joint guideline on radiation therapy after prostatectomy for patients with and without evidence of prostate cancer recurrence.
[More]
By developing a new way to compare techniques for teaching robotic surgery, doctors at The Methodist Hospital and the University of Southern California report in an upcoming issue of the British Journal of Urology International that surgeons training in robotic surgery learned best when three different teaching methods were used.
[More]
The incidence of testicular cancer has increased among American males over 15 years of age for more than 20 years and while overall incidence is still highest among Caucasian males, the greatest increase was observed in the Hispanic community, according to a new study at the 108th Annual Scientific Meeting of the American Urological Association.
[More]
Men ages 55 to 69 who are considering prostate cancer screening should talk with their doctors about the benefits and harms of testing and proceed based on their personal values and preferences, according to a new clinical practice guideline released today by the American Urological Association.
[More]
A relatively common urinary tract disorder that can usually be managed in an outpatient setting is adding an estimated $238 million a year to the cost of emergency room visits in the U.S., according to two new studies from Henry Ford Hospital in Detroit.
[More]
Laparoscopic radical nephrectomy is an effective treatment approach for individuals with renal cell carcinoma who have larger or more advanced renal masses, report researchers.
[More]
US researchers have put forward a risk stratification system for patients with intermediate-risk prostate cancer undergoing dose-escalated external-beam radiation therapy.
[More]